Go to Top

Bydureon vs. Victoza? Super Bowl? M2 makes our prediction

Metabolic Markets has developed a GLP-1 market briefing for our clients education and discussion. Entitled: "The U.S. GLP-1 Market Brief: Yesterday, Today, and Tomorrow"  The brief slide deck reviews the history of Byetta, shares our clinical and commercial experience, Victoza introduction, and short term considerations to watch as the market unfolds with the pending Bydureon launch.

Available to you, dear reader,  for only the cost of an email: aaron@metabolicmarkets.com